Ab Initio Pharma, a formulation and manufacturing company, established as a spinoff by the University of Sydney in partnership with Sydney Local Health Distinct. The company will provide formulation support and product manufacture of non-sterile therapeutics that meets national and international pharmaceutical regulatory standards. Ab Initio also has R&D facilities that is able to offer its partners formulation services to develop products suitable for clinical trials.
Ab Initio Pharma has not received any reviews.
Ab Initio Pharma has not received any endorsements.